Olema Pharmaceuticals Newsroom

LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $29

Futu NewsOct 25 07:36

Capital One Financial Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $26

Futu NewsOct 24 20:31

Promising Potential of Olema Pharmaceuticals' Palazestrant and KAT6 Inhibitor Fuels Buy Rating

TipRanksOct 24 19:57

Olema Pharmaceuticals Analyst Ratings

BenzingaOct 24 17:45

H.C. Wainwright Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $30

Futu NewsOct 24 00:31

Buy Rating for Olema Pharmaceuticals: Promising Preclinical Data and Strategic Pipeline Synergy

TipRanksOct 24 00:09

Goldman Sachs Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Raises Target Price to $27

Futu NewsSep 11 00:31

Olema Pharmaceuticals Analyst Ratings

BenzingaAug 9 00:24

JP Morgan Maintains Overweight on Olema Pharmaceuticals, Lowers Price Target to $31

BenzingaAug 9 00:24

Olema Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow JonesAug 8 04:43

Oppenheimer Reiterates Outperform on Olema Pharmaceuticals, Maintains $30 Price Target

BenzingaAug 8 02:00

Olema Pharmaceuticals Analyst Ratings

BenzingaAug 8 01:59

Buy Rating Reaffirmed for Olema Pharmaceuticals Amid Promising Breast Cancer Treatment Advances and Strong Financials

TipRanksAug 7 20:37

Buy Rating Affirmed for Olema Pharmaceuticals Amidst Promising Clinical Developments and Strategic Collaborations

TipRanksAug 7 06:47

Olema Pharmaceuticals Analyst Ratings

BenzingaJun 4 19:05

Buy Rating Affirmed for Olema Pharmaceuticals on Strong Clinical Trial Data for Palazestrant and Ribociclib Combination

TipRanksMay 16 18:11

Buy Rating Justified by Promising Efficacy and Safety Profile of Olema Pharmaceuticals' Drug Combination in Clinical Studies

TipRanksMay 16 03:50

Olema Pharmaceuticals Analyst Ratings

BenzingaMay 16 02:00

HC Wainwright & Co. Reiterates Buy on Olema Pharmaceuticals, Maintains $30 Price Target

BenzingaMay 16 02:00

Promising Clinical Trial Results Bolster Buy Rating for Olema Pharmaceuticals

TipRanksMay 15 23:50